Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
20,062.24
-49.37
-0.25%
Nifty
6,094.50
-19.60
-0.32%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Panacea Biotec Ltd
BSE: 531349 | NSE: PANACEABIO | ISIN: INE922B01023
Market Cap: [Rs.Cr.] 625 | Face Value: [Rs.] 1
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Discuss this stock
Finished Goods
Mar 2012
Mar 2011
Mar 2010
Mar 2009
Mar 2008
Mar 2007
Mar 2006
Mar 2005
Mar 2004
Mar 2003
Product Name
Unit
value (Rs.Cr)
Qty (Nos.)
%Sales Turnover
Sale of raw material
Rs.
0.00
0
0.00
Income from Contract Manufactu
NA
4.59
0
0.65
Services (R & D Income)
NA
0.00
0
0.00
Bacterial Bulk Vaccines
Dos
0.00
0
0.00
Other Operating Revenue
NA
12.20
0
1.74
Other Products
Gms
0.00
0
0.00
Adjustments
NA
-0.05
0
-0.01
Husk
Gms
0.00
0
0.00
Biscuits-Traded
No
0.00
0
0.00
Cell Culture Block
Doz
0.00
0
0.00
Flu Bulk Vaccine Block
Doz
0.00
0
0.00
Vaccines
Dos
0.00
0
0.00
Vaccines
via
357.87
0
51.01
Polio Vaccine
No
0.00
0
0.00
Recombinant Bulk Vaccine
Dos
0.00
0
0.00
Tetanus Bulk Vaccines
Dos
0.00
0
0.00
Capsules
No
0.00
0
0.00
Capsules-Traded
No
0.00
0
0.00
Formulation-Traded
NA
54.45
0
7.76
Gels
Gms
0.00
0
0.00
Gels - Traded
Gms
0.00
0
0.00
Gels (Tubes)
No
0.00
0
0.00
Granules
No
0.00
0
0.00
Injections
No
0.00
0
0.00
Injections
via
0.00
0
0.00
Injections-Traded
via
0.00
0
0.00
Syrups
BOT
0.00
0
0.00
Syrups/Liquids (MI)
Ltr
0.00
0
0.00
Syrups/Liquids (MI) - Traded
Ltr
0.00
0
0.00
Tablets
No
0.00
0
0.00
Tablets-Traded
No
0.00
0
0.00
Formulations
NA
272.50
0
38.84
Granules - Traded
No
0.00
0
0.00
Kits
No
0.00
0
0.00
Pre Filled Syringes
PFS
0.00
0
0.00
Pre-Filled Syringes
Dos
0.00
0
0.00
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
10-May-13
Panacea Biotec - Board to consider Dividend
08-Feb-13
Panacea Biotec reports net loss of Rs 62.28 crore in the December 2012 quarter
17-Dec-12
Panacea Biotec bags order for supply of oral polio vaccine worth Rs 187 crore
20-Nov-12
Panacea Biotec surges 5.6% in 2 days
19-Nov-12
Panacea Biotec gallops on strategic alliance with Kremers Urban Inc.
19-Nov-12
Panacea Biotec enters into a strategic alliance with Kremers Urban
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds.
103,756.76
72.08
12.80
27.45
26.1
27.0
0.01
Dr Reddy's Labs
34,924.33
27.60
4.59
18.79
14.3
16.6
0.25
Cipla
33,340.42
21.78
4.42
14.11
15.9
19.8
0.03
Ranbaxy Labs.
18,239.84
0.00
9.50
72.87
0.0
0.0
2.38
Wockhardt
18,015.50
107.31
149.73
12.82
237.0
30.3
2.09
Cadila Health.
16,103.82
39.03
6.32
18.45
28.4
24.2
0.40
Glenmark Pharma.
15,251.67
39.51
6.04
23.94
12.7
11.7
0.39
Piramal Enterp.
9,814.64
0.00
0.93
23.66
0.8
2.1
0.07
Ipca Labs.
7,355.57
22.12
5.83
10.09
24.2
23.7
0.49
Torrent Pharma.
6,077.41
11.37
4.66
11.66
29.6
25.5
0.48
Biocon
5,595.00
19.51
2.54
12.20
12.6
13.6
0.08
Aurobindo Pharma
5,307.12
12.62
2.13
22.89
10.7
8.8
1.01
Strides Arcolab
5,226.52
35.63
3.81
46.94
7.3
8.9
0.56
Mylan Lab.
3,273.19
6.80
1.77
0.00
26.9
26.1
0.59
Alembic Pharma
2,343.06
14.89
5.10
5.60
39.5
27.7
1.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Soshil Kumar Jain , Chairman & Wholetime Director
Ravinder Jain , Managing Director
Rajesh Jain , Joint Managing Director
Sandeep Jain , Joint Managing Director
Company Head Office / Quarters:
Ambala-Chandigarh Highway,
,
Lalru,
Punjab-140501
Phone : 91-1762-505900 (30 Lines)
Fax : 91-1762-505900/9/6
E-mail :
companysec@panaceabiotec.com
Web :
http://www.panaceabiotec.com
Registrars:
Skyline Financial Services Pvt
D-153/A 1st Flr
Okhla Industrial Are
Phase-I
New Delhi-110020
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
No IPO today
View full month IPO calendar
Economic Events
Foreign Buying Japan Stocks (Yen)
Exports (New Zealand dollars)
View full month Economic Events calendar
Results
Tata Steel | St Bk of India | B H E L | Hind.Copper
View full month Results calendar